VivoSim Labs, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VivoSim Labs, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $14.00K.
- VivoSim Labs, Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-03-31 was $0.00.
- VivoSim Labs, Inc. stock issued during period, value, stock options exercised for the quarter ending 2018-12-31 was $50.00K.
- VivoSim Labs, Inc. stock issued during period, value, stock options exercised for the quarter ending 2014-03-31 was $207.00K.
- VivoSim Labs, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $42.00K.
- VivoSim Labs, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $50.00K, a 93.95% decline from fiscal 2018.
- VivoSim Labs, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $826.00K.
- VivoSim Labs, Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $320.00K, a 8.83% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-03-31 | $42.00K 10-K · filed 2022-06-10 | |
| 2020-09-30 | $14.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $50.00K 10-K · filed 2020-05-28 |
| 2018-12-31 | $50.00K 10-Q · filed 2020-02-10 | |
| 2018-03-31 | $826.00K 10-K · filed 2019-06-03 | |
| 2016-03-31 | $320.00K 10-K · filed 2018-05-31 | |
| 2015-03-31 | $351.00K 10-K · filed 2017-06-07 | |
| 2014-03-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | $402.00K 10-K · filed 2016-06-09 |
| 2013-12-31 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | |
| 2012-12-31 | $75.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-09 | $18.00K 10-K · filed 2015-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |